P2 Capital Partners’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.5M | Buy |
+1,774,484
| New | +$32.1M | 19.77% | 1 |
|
|
2025
Q4 | – | Sell |
-2,337,188
| Closed | -$57.9M | – | 11 |
|
|
2025
Q3 | $57.9M | Buy |
2,337,188
+195,000
| +9% | +$4.35M | 11.12% | 3 |
|
|
2025
Q2 | $48.6M | Hold |
2,142,188
| – | – | 9.3% | 3 |
|
|
2025
Q1 | $65M | Sell |
2,142,188
-52,100
| -2% | -$1.99M | 12.61% | 3 |
|
|
2024
Q4 | $87M | Buy |
2,194,288
+624,288
| +40% | +$28.2M | 14.78% | 2 |
|
|
2024
Q3 | $99.6M | Buy |
1,570,000
+60,000
| +4% | +$4.33M | 11.37% | 3 |
|
|
2024
Q2 | $102M | Buy |
1,510,000
+210,000
| +16% | +$14.7M | 11.18% | 1 |
|
|
2024
Q1 | $103M | Sell |
1,300,000
-70,000
| -5% | -$5.72M | 12.17% | 2 |
|
|
2023
Q4 | $107M | Hold |
1,370,000
| – | – | 11.72% | 3 |
|
|
2023
Q3 | $96.3M | Hold |
1,370,000
| – | – | 12.6% | 3 |
|
|
2023
Q2 | $109M | Hold |
1,370,000
| – | – | 12.7% | 3 |
|
|
2023
Q1 | $99M | Hold |
1,370,000
| – | – | 12.69% | 3 |
|
|
2022
Q4 | $113M | Sell |
1,370,000
-230,000
| -14% | -$19M | 14.91% | 2 |
|
|
2022
Q3 | $125M | Sell |
1,600,000
-20,000
| -1% | -$1.6M | 15.44% | 2 |
|
|
2022
Q2 | $110M | Sell |
1,620,000
-65,000
| -4% | -$4.53M | 12.41% | 2 |
|
|
2022
Q1 | $110M | Sell |
1,685,000
-259,293
| -13% | -$15.1M | 10.45% | 2 |
|
|
2021
Q4 | $118M | Hold |
1,944,293
| – | – | 9.2% | 3 |
|
|
2021
Q3 | $124M | Sell |
1,944,293
-164,900
| -8% | -$10.4M | 10.45% | 1 |
|
|
2021
Q2 | $132M | Sell |
2,109,193
-420,249
| -17% | -$26.4M | 9.93% | 2 |
|
|
2021
Q1 | $145M | Sell |
2,529,442
-745,036
| -23% | -$40.3M | 9.59% | 2 |
|
|
2020
Q4 | $165M | Sell |
3,274,478
-2,300,601
| -41% | -$91.7M | 11.17% | 1 |
|
|
2020
Q3 | $164M | Hold |
5,575,079
| – | – | 12.86% | 1 |
|
|
2020
Q2 | $140M | Hold |
5,575,079
| – | – | 11.7% | 1 |
|
|
2020
Q1 | $102M | Hold |
5,575,079
| – | – | 12.23% | 2 |
|
|
2019
Q4 | $185M | Sell |
5,575,079
-884,921
| -14% | -$27.7M | 13.59% | 2 |
|
|
2019
Q3 | $201M | Buy |
6,460,000
+2,181,276
| +51% | +$66.4M | 13.57% | 2 |
|
|
2019
Q2 | $150M | Hold |
4,278,724
| – | – | 11.43% | 3 |
|
|
2019
Q1 | $125M | Buy |
4,278,724
+1,115,000
| +35% | +$31.6M | 10.42% | 3 |
|
|
2018
Q4 | $81.3M | Buy |
3,163,724
+1,063,724
| +51% | +$36.8M | 8.21% | 4 |
|
|
2018
Q3 | $73.9M | Sell |
2,100,000
-227,961
| -10% | -$9.08M | 6.63% | 5 |
|
|
2018
Q2 | $95.2M | Sell |
2,327,961
-1,022,039
| -31% | -$41.2M | 9.66% | 2 |
|
|
2018
Q1 | $131M | Buy |
3,350,000
+425,000
| +15% | +$15.6M | 12.77% | 2 |
|
|
2017
Q4 | $95.4M | Buy |
2,925,000
+1,771,814
| +154% | +$61.4M | 11.26% | 3 |
|
|
2017
Q3 | $55.1M | Sell |
1,153,186
-217,100
| -16% | -$10.6M | 6.44% | 8 |
|
|
2017
Q2 | $67.7M | Buy |
1,370,286
+876,659
| +178% | +$38.8M | 7.87% | 7 |
|
|
2017
Q1 | $21.5M | Buy |
+493,627
| New | +$20M | 3.02% | 11 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
P2 Capital Partners's ACHC Position: Q1 2026 in Review
P2 Capital Partners opened a new position in Acadia Healthcare (ACHC) in Q1 2026: 1,774,484 shares worth $41.5M. The stake represents 19.77% of the portfolio and ranks #1 among its holdings. This is a return to the name: P2 Capital Partners previously reported a position in ACHC as recently as Q3 2025.
P2 Capital Partners first reported a position in ACHC in Q1 2017 and has held it in 36 quarters since. The position peaked at $201M in Q3 2019. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- P2 Capital Partners held 1,774,484 shares of Acadia Healthcare worth $41.5M as of Q1 2026.
- Acadia Healthcare was a new P2 Capital Partners position in Q1 2026.
- Acadia Healthcare made up 19.77% of P2 Capital Partners's portfolio in Q1 2026, its #1 holding.
- P2 Capital Partners first reported a position in Acadia Healthcare in Q1 2017 and has held it in 36 quarters since.
- P2 Capital Partners's Acadia Healthcare position peaked at $201M in Q3 2019.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on P2 Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.